$RSPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RespireRx Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RespireRx Pharmaceuticals Inc.. Get notifications about new insider transactions in RespireRx Pharmaceuticals Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13 2008 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.86 | 30,000 | 25,800 | 30,000 | |
Feb 13 2008 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.86 | 30,000 | 25,800 | 30,000 | |
Feb 13 2008 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 0.86 | 30,000 | 25,800 | 30,000 | |
Feb 13 2008 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 0.86 | 30,000 | 25,800 | 30,000 | |
Feb 13 2008 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 0.86 | 30,000 | 25,800 | 30,000 | |
Jan 25 2008 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 0.58 | 10,000 | 5,800 | 80,000 | 70 K to 80 K (+14.29 %) |
Jan 24 2008 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 0.57 | 10,000 | 5,700 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 22 2008 | RSPI | RespireRx Pharmace ... | Tran Pierre V | Chief Medical Offic ... | Option Exercise | A | 0.54 | 50,000 | 27,000 | 50,000 | |
Jan 22 2008 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Jan 22 2008 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Option Exercise | A | 0.54 | 200,000 | 108,000 | 200,000 | |
Jan 22 2008 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Option Exercise | A | 0.54 | 100,000 | 54,000 | 100,000 | |
Jan 22 2008 | RSPI | RespireRx Pharmace ... | Johnson Steven Andrew | VP, Preclinical Dev ... | Option Exercise | A | 0.54 | 100,000 | 54,000 | 100,000 | |
Jan 22 2008 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Option Exercise | A | 0.54 | 100,000 | 54,000 | 100,000 | |
Dec 21 2007 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Buy | P | 0.53 | 16,000 | 8,480 | 28,000 | 12 K to 28 K (+133.33 %) |
Dec 14 2007 | RSPI | RespireRx Pharmace ... | Tran Pierre V | Chief Medical Offic ... | Buy | P | 0.63 | 10,000 | 6,300 | 30,000 | 20 K to 30 K (+50.00 %) |
Dec 14 2007 | RSPI | RespireRx Pharmace ... | Tran Pierre V | Chief Medical Offic ... | Buy | P | 0.62 | 4,500 | 2,790 | 20,000 | 15.5 K to 20 K (+29.03 %) |
Dec 14 2007 | RSPI | RespireRx Pharmace ... | Tran Pierre V | Chief Medical Offic ... | Buy | P | 0.61 | 13,300 | 8,113 | 15,500 | 2.2 K to 15.5 K (+604.55 %) |
Dec 14 2007 | RSPI | RespireRx Pharmace ... | Tran Pierre V | Chief Medical Offic ... | Buy | P | 0.60 | 2,200 | 1,320 | 2,200 | 0 to 2.2 K |
Dec 12 2007 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 0.65 | 10,000 | 6,500 | 60,000 | 50 K to 60 K (+20.00 %) |
Dec 07 2007 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | M | 0.38 | 6,000 | 2,250 | 0 | |
Dec 07 2007 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Buy | M | 0.38 | 6,000 | 2,250 | 59,500 | 53.5 K to 59.5 K (+11.21 %) |
Nov 30 2007 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Buy | P | 0.50 | 15,000 | 7,500 | 15,000 | 0 to 15 K |
Nov 27 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.48 | 12,385 | 5,945 | 30,000 | 17.6 K to 30 K (+70.31 %) |
Nov 27 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.48 | 1,500 | 720 | 17,615 | 16.1 K to 17.6 K (+9.31 %) |
Nov 27 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.49 | 5,000 | 2,450 | 16,115 | 11.1 K to 16.1 K (+44.98 %) |
Nov 23 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.46 | 7,115 | 3,273 | 11,115 | 4 K to 11.1 K (+177.88 %) |
Nov 23 2007 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Buy | P | 0.45 | 4,000 | 1,800 | 4,000 | 0 to 4 K |
Nov 21 2007 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 0.51 | 10,000 | 5,100 | 50,000 | 40 K to 50 K (+25.00 %) |
Nov 19 2007 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Buy | P | 0.48 | 4,650 | 2,232 | 200,397 | 195.7 K to 200.4 K (+2.38 %) |
Nov 16 2007 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 0.50 | 10,000 | 5,000 | 40,000 | 30 K to 40 K (+33.33 %) |
Nov 16 2007 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Buy | P | 0.49 | 24,700 | 12,103 | 195,747 | 171 K to 195.7 K (+14.44 %) |
Nov 14 2007 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Buy | P | 0.50 | 10,700 | 5,350 | 50,000 | 39.3 K to 50 K (+27.23 %) |
Nov 14 2007 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Buy | P | 0.49 | 39,300 | 19,257 | 39,300 | 0 to 39.3 K |
Nov 15 2007 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Option Exercise | M | 0.38 | 15,000 | 5,625 | 0 | |
Nov 15 2007 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Buy | M | 0.38 | 15,000 | 5,625 | 30,000 | 15 K to 30 K (+100.00 %) |
Nov 15 2007 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Buy | P | 0.49 | 5,000 | 2,450 | 15,000 | 10 K to 15 K (+50.00 %) |
Nov 14 2007 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Buy | P | 0.50 | 30,000 | 15,000 | 30,000 | 0 to 30 K |
Nov 14 2007 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 3,000 | 1,125 | 0 | |
Nov 14 2007 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Buy | M | 0.38 | 3,000 | 1,125 | 71,500 | 68.5 K to 71.5 K (+4.38 %) |
Nov 13 2007 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Buy | P | 0.49 | 42,400 | 20,776 | 171,047 | 128.6 K to 171 K (+32.96 %) |
Nov 09 2007 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Buy | P | 0.48 | 100 | 48 | 128,647 | 128.5 K to 128.6 K (+0.08 %) |
Nov 09 2007 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Buy | P | 0.49 | 40,000 | 19,600 | 128,547 | 88.5 K to 128.5 K (+45.17 %) |
Oct 16 2007 | RSPI | RespireRx Pharmace ... | Tran Pierre V | Chief Medical Offic ... | Option Exercise | A | 0.66 | 750,000 | 495,000 | 750,000 | |
Mar 01 2007 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Option Exercise | J | 3.02 | 50,000 | 150,780 | 50,000 | |
Feb 07 2007 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Option Exercise | A | 1.12 | 25,000 | 28,000 | 25,000 | |
Feb 07 2007 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 1.12 | 25,000 | 28,000 | 25,000 | |
Feb 07 2007 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 1.12 | 25,000 | 28,000 | 25,000 | |
Feb 07 2007 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 1.12 | 25,000 | 28,000 | 25,000 | |
Feb 07 2007 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 1.12 | 25,000 | 28,000 | 25,000 | |
Feb 07 2007 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 1.12 | 25,000 | 28,000 | 25,000 | |
Feb 07 2007 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 1.12 | 25,000 | 28,000 | 25,000 | |
Dec 20 2006 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Option Exercise | A | 1.30 | 250,000 | 325,000 | 250,000 | |
Dec 20 2006 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Option Exercise | A | 1.30 | 300,000 | 390,000 | 300,000 | |
Dec 20 2006 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Option Exercise | A | 1.30 | 125,000 | 162,500 | 125,000 | |
Dec 20 2006 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Option Exercise | A | 1.30 | 125,000 | 162,500 | 125,000 | |
Dec 08 2006 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 4,750 | 1,781 | 0 | |
Dec 08 2006 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 500 | 188 | 0 | |
Dec 08 2006 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 10,000 | 3,750 | 0 | |
Dec 08 2006 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 3,000 | 1,125 | 0 | |
Dec 08 2006 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Buy | M | 0.38 | 18,250 | 6,844 | 68,500 | 50.3 K to 68.5 K (+36.32 %) |
Nov 30 2006 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | M | 0.38 | 6,000 | 2,250 | 0 | |
Nov 30 2006 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Buy | M | 0.38 | 6,000 | 2,250 | 53,500 | 47.5 K to 53.5 K (+12.63 %) |
Mar 22 2006 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 5,000 | 1,875 | 0 | |
Mar 22 2006 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Buy | M | 0.38 | 5,000 | 1,875 | 100,500 | 95.5 K to 100.5 K (+5.24 %) |
Jan 31 2006 | RSPI | RespireRx Pharmace ... | Varney Mark A | Chief Scientific Of ... | Option Exercise | A | 2.95 | 750,000 | 2,212,500 | 750,000 | |
Feb 13 2006 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Option Exercise | A | 2.95 | 205,017 | 604,800 | 205,017 | |
Jan 30 2006 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Gift | G | 0.00 | 15,153 | 0 | 0 | 15.2 K to 0 (-100.00 %) |
Jan 30 2006 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Gift | G | 0.00 | 2,500 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 13 2005 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | M | 0.38 | 2,500 | 938 | 0 | |
Dec 13 2005 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Buy | M | 0.38 | 2,500 | 938 | 95,500 | 93 K to 95.5 K (+2.69 %) |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Option Exercise | A | 2.35 | 300,000 | 705,000 | 300,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Option Exercise | A | 2.35 | 100,000 | 235,000 | 100,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | Mansbach Harry H | Chief Medical Offic ... | Option Exercise | A | 2.35 | 100,000 | 235,000 | 100,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | ROGERS GARY ALLEN | Sr VP, Pharmaceutic ... | Option Exercise | A | 2.35 | 100,000 | 235,000 | 100,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Option Exercise | A | 2.35 | 100,000 | 235,000 | 100,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Option Exercise | A | 2.35 | 25,000 | 58,750 | 25,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 2.35 | 25,000 | 58,750 | 25,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 2.35 | 25,000 | 58,750 | 25,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 2.35 | 25,000 | 58,750 | 25,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 2.35 | 25,000 | 58,750 | 25,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | Benedik John F | Director | Option Exercise | A | 2.35 | 30,000 | 70,500 | 30,000 | |
Dec 05 2005 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 2.35 | 25,000 | 58,750 | 25,000 | |
Nov 04 2005 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | M | 0.38 | 17,500 | 6,563 | 0 | |
Nov 04 2005 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Buy | M | 0.38 | 17,500 | 6,563 | 47,500 | 30 K to 47.5 K (+58.33 %) |
Sep 22 2005 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Buy | P | 2.30 | 12,000 | 27,600 | 12,000 | 0 to 12 K |
Apr 05 2005 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Option Exercise | M | 0.38 | 10,000 | 3,750 | 15,000 | |
Apr 05 2005 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Buy | M | 0.38 | 10,000 | 3,750 | 10,000 | 0 to 10 K |
Mar 15 2005 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 2.50 | 1,900 | 4,750 | 30,000 | 28.1 K to 30 K (+6.76 %) |
Mar 15 2005 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Buy | P | 2.45 | 3,100 | 7,595 | 28,100 | 25 K to 28.1 K (+12.40 %) |
Jan 28 2005 | RSPI | RespireRx Pharmace ... | ROGERS GARY ALLEN | Sr VP, Pharmaceutic ... | Option Exercise | M | 0.38 | 49,333 | 18,500 | 0 | |
Jan 28 2005 | RSPI | RespireRx Pharmace ... | ROGERS GARY ALLEN | Sr VP, Pharmaceutic ... | Buy | M | 0.38 | 49,333 | 18,500 | 127,700 | 78.4 K to 127.7 K (+62.95 %) |
Feb 09 2005 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 0.38 | 4,031 | 1,512 | 0 | |
Feb 09 2005 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 0.38 | 7,846 | 2,942 | 0 | |
Feb 09 2005 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | M | 0.38 | 3,276 | 1,229 | 0 | |
Feb 09 2005 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Buy | M | 0.38 | 15,153 | 5,682 | 17,653 | 2.5 K to 17.7 K (+606.12 %) |
Feb 09 2005 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Buy | P | 2.67 | 2,500 | 6,675 | 2,500 | 0 to 2.5 K |
Dec 21 2004 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Buy | P | 2.66 | 4,000 | 10,640 | 30,000 | 26 K to 30 K (+15.38 %) |
Dec 17 2004 | RSPI | RespireRx Pharmace ... | STOLL ROGER G PHD | Chief Executive Off ... | Option Exercise | A | 2.68 | 300,000 | 804,000 | 300,000 | |
Dec 17 2004 | RSPI | RespireRx Pharmace ... | MESSINGER MARIA S | Chief Financial Off ... | Option Exercise | A | 2.68 | 100,000 | 268,000 | 100,000 | |
Dec 17 2004 | RSPI | RespireRx Pharmace ... | COLEMAN JAMES H | Sr. VP, Business De ... | Option Exercise | A | 2.68 | 100,000 | 268,000 | 100,000 | |
Dec 17 2004 | RSPI | RespireRx Pharmace ... | ROGERS GARY ALLEN | Sr VP, Pharmaceutic ... | Option Exercise | A | 2.68 | 100,000 | 268,000 | 100,000 | |
Dec 16 2004 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
Dec 16 2004 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
Dec 16 2004 | RSPI | RespireRx Pharmace ... | JOHNSON M ROSS | Director | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
Dec 16 2004 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
Dec 16 2004 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
Dec 16 2004 | RSPI | RespireRx Pharmace ... | CASAMENTO CHARLES J | Director | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
Dec 16 2004 | RSPI | RespireRx Pharmace ... | ALLNUTT ROBERT | Director | Option Exercise | A | 2.68 | 25,000 | 67,000 | 25,000 | |
Dec 02 2004 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.38 | 9,500 | 3,563 | 9,500 | |
Dec 02 2004 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | D | 0.38 | 9,500 | 3,563 | 0 | |
Dec 02 2004 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | A | 0.38 | 21,000 | 7,875 | 21,000 | |
Dec 02 2004 | RSPI | RespireRx Pharmace ... | COTMAN CARL W | Director | Option Exercise | D | 0.38 | 21,000 | 7,875 | 0 | |
Sep 01 2004 | RSPI | RespireRx Pharmace ... | Mansbach Harry H | Chief Medical Offic ... | Option Exercise | A | 2.13 | 400,000 | 852,000 | 400,000 | |
Sep 01 2004 | RSPI | RespireRx Pharmace ... | Mansbach Harry H | Chief Medical Offic ... | Grant | A | 0.00 | 100,000 | 0 | 107,000 | 7 K to 107 K (+1,428.57 %) |
May 24 2004 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Option Exercise | A | 2.20 | 150,000 | 330,000 | 150,000 | |
Apr 05 2004 | RSPI | RespireRx Pharmace ... | TOLLEFSON GARY D | Director | Option Exercise | A | 2.78 | 30,000 | 83,400 | 30,000 |